Q4 2025 Earnings Call February 27, 2026 8:00 AM ESTCompany ParticipantsTrip TaylorJohn Treace - Founder, Chairman ...

About Treace Medical Concepts Inc. Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion ...

PONTE VEDRA, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...

Studies show that one third of men and women in the U.S. have a bunion. It's a bone that sticks out of your foot that can cause excruciating pain. Experts say they’re mostly caused by genetics, but ...

Treace Medical Concepts Inc. reported a revenue decline for Q4 2025, with earnings per share falling short of expectations. The company’s revenue reached $62.5 million, marking a 9% decrease from the ...

The company initiated 2026 full-year revenue guidance between $200 million and $212 million, representing a decline of 6% to 0% versus 2025. Management explained that revenue declines are expected ...

Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot ...

Treace Medical Concepts, Inc. - GlobeNewswire - Tue Feb 24, 6:05AM CST PONTE VEDRA, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), ...

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Why the Fair Value and Price Targets Are Moving The recent shift in Treace Medical ...